On June 3rd, within the framework of the XXIX St. Petersburg International Economic Forum (SPIEF), a session of the BRICS 女性商业联盟 was held, titled “BRICS – What Unites Us: Shared Victories and New Opportunities for Women’s Entrepreneurship.”

During the panel session, BRICS practical developments and initiatives in the fields of recruitment, light industry, healthcare, education, and social entrepreneurship were presented.

会议由 安娜·内斯特罗娃, Chairperson of the Russian Chapter of the BRICS Women’s Business Alliance. During the speech, Anna underlined:

“It must be acknowledged that behind every catchy phrase about ‘expanding and deepening cooperation’ there are practical developments and real cases of launched
and implemented projects.”

安娜·内斯特罗娃

Chairperson of the Russian Chapter of the BRICS Women’s Business Alliance

The session also featured speeches by:

• 柳德米拉·谢尔巴科娃, President of Velpharm Group of Companies;
• Chioma Dozie, Pharmacist Director of Dochiva Pharmatech Nig Ltd;
• Alsu Nabiyeva, Rector of the Russian University of Cooperation;
• 迈卡·努尔哈亚蒂, Representative of the BRICS Women’s Business Alliance Indonesia Chapter, Vice Chairperson of the Healthcare Affairs of the Indonesian Association of Women Entrepreneurs;
• Tatyana Lugina, General Director of Kamvol, Chairperson of the BRICS Women’s Business Alliance Regional Office in Belarus;
• 加琳娜·沃尔科娃, Founder of Special Purpose Footwear Design Center “Ortomoda”;
• Natalia Vershinina-Adelman, Head of the BRICS Mobility international project, expert in international recruitment and provision of foreign personnel, CEO of the Private Employment Agency Regional Labor Exchange LLC.

Chioma Dozie, Pharmacist Director of Dochiva Pharmatech Nig Ltd, delivered her remarks underlining the role of BRICS in implementing and promoting joint projects:

BRICS posses unique strategic resources and a unified regulatory harmonization framework would even enhance this potential.

Chioma Dozie

Pharmacist Director of Dochiva Pharmatech Nig Ltd

柳德米拉·谢尔巴科娃, President of Velpharm Group of Companies, also adressed the session emphasizing the role of pharmaceuticals cooperation in the BRICS countries:

Interest in pharmaceutical cooperation is extremely high, especially when it comes to medicine safety. Our partners need new technologies in this area and we are ready to provide them.

柳德米拉·谢尔巴科娃

President of Velpharm Group of Companies

The session served as a platform for seeking multilateral synergy. For example, the parties discussed the prospects for enterpreneurial cooperation, found a common ground in healthcare, education and other spheres and expressed readiness for further engagement.